ScholarIQanswers from OpenAlex & ORCID
Séverine Bompoint
ResearcherPublications, citations & collaboration network
Séverine Bompoint is a researcher indexed in ScholarIQ from OpenAlex & ORCID.
How many works does Séverine Bompoint have?
ScholarIQindexed works
Séverine Bompoint has 32 works in the ScholarIQ index. The count is the OpenAlex total, not the number of papers listed on this page.
How many citations does Séverine Bompoint have?
ScholarIQcitation count
Séverine Bompoint has 16,365 citations in the OpenAlex counts ScholarIQ stores.
What is the h-index of Séverine Bompoint?
ScholarIQh-index
Séverine Bompoint has an h-index of 16 in OpenAlex.
What is the i10-index of Séverine Bompoint?
ScholarIQi10-index
Séverine Bompoint has an i10-index of 17 in OpenAlex.
What is the ORCID of Séverine Bompoint?
ScholarIQorcid
The ORCID for Séverine Bompoint is on the source record.
What is the OpenAlex record for Séverine Bompoint?
ScholarIQopenalex
The OpenAlex for Séverine Bompoint is on the source record.
What are the most-cited papers on Séverine Bompoint?
ScholarIQmost cited works
Intensive Blood Glucose Control and Vascular Outcomes in Patients with Type 2 Diabetes
The ADVANCE Collaborative Group
Canagliflozin and Renal Outcomes in Type 2 Diabetes and Nephropathy
Vlado Perkovic, Meg Jardine, Bruce Neal, Séverine Bompoint, Hiddo J.L. Heerspink, David M. Charytan, Robert Edwards, Rajiv Agarwal, George L. Bakris, Scott Bull, Christopher P. Cannon, George Capuano, Pei-Ling Chu, Dick de Zeeuw, Tom Greene, Adeera Levin, Carol A. Pollock, David C. Wheeler, Yshai Yavin, Hong Zhang, Bernard Zinman, Gary Meininger, Barry M. Brenner, Kenneth W. Mahaffey
SGLT2 inhibitors for the prevention of kidney failure in patients with type 2 diabetes: a systematic review and meta-analysis
Brendon L. Neuen, T. Kue Young, Hiddo J.L. Heerspink, Bruce Neal, Vlado Perkovic, Laurent Billot, Kenneth W. Mahaffey, David M. Charytan, David C. Wheeler, Clare Arnott, Séverine Bompoint, Adeera Levin, Meg Jardine
Canagliflozin and Cardiovascular and Renal Outcomes in Type 2 Diabetes Mellitus and Chronic Kidney Disease in Primary and Secondary Cardiovascular Prevention Groups
Kenneth W. Mahaffey, Meg Jardine, Séverine Bompoint, Christopher P. Cannon, Bruce Neal, Hiddo J.L. Heerspink, David M. Charytan, Robert Edwards, Rajiv Agarwal, George L. Bakris, Scott Bull, George Capuano, Dick de Zeeuw, Tom Greene, Adeera Levin, Carol A. Pollock, Tao Sun, David C. Wheeler, Yshai Yavin, Hong Zhang, Bernard Zinman, Norman Rosenthal, Barry M. Brenner, Vlado Perkovic, On behalf of the CREDENCE Study Investigators
Sodium‐Glucose Cotransporter 2 Inhibition for the Prevention of Cardiovascular Events in Patients With Type 2 Diabetes Mellitus: A Systematic Review and Meta‐Analysis
Clare Arnott, Qiang Li, Amy Kang, Brendon L. Neuen, Séverine Bompoint, Carolyn S.P. Lam, Anthony Rodgers, Kenneth W. Mahaffey, Christopher P. Cannon, Vlado Perkovic, Meg Jardine, Bruce Neal